Using advanced CRISPR-Cas9 functional genetics to model and probe T cell acute lymphoblastic leukemia (T-ALL)

Category

Thesis advisor:

GND

134010256

ORCID

0000-0001-5684-2280

Schwarzer, Adrian;

GND

128643250

ORCID

0000-0003-2743-0070

Schambach, Axel;

GND

130051918

ORCID

0000-0001-5318-9044

Heuser, Michael;

GND

1015426832

ORCID

0000-0003-4047-975X

Heckl, Dirk

Host institution:

GND

2019538-2

Medizinische Hochschule Hannover 17.05.1965 -;

GND

10186552-1

Hannover Biomedical Research School 2003 -;

GND

1026380278

Medizinische Hochschule Hannover Institut Experimentelle Hämatologie; ;

Date accepted:

2023

Date Issued:

2024

DOI:

10.26068/mhhrpm/20240701-000

PPN:

1852261692

Language:

English

Type of Resource:

Text

Extent:

3 ungezählte Blätter, 163 Blätter

Place Term:

Hannover

Place of Origin:

Hannover

Publisher (creation):

Medizinische Hochschule

DDC subject of DNB:

610 Medical sciences Medicine

Library shelfmark::

D 82876

Hosting institution:

Central Facilities, Hannover Biomedical Research School (HBRS)

Hosting institution:

Hospitals and Institutes, Institute of Experimental Hemalogy

accrual policy:

CD-ROM enthält: 4 Textdokumente und 1 Excel-Tabelle

content:

CRISPR associated protein 9

statement of responsibility:

by Maximilian Schinke, M.Sc. Biomedicine ; Hannover Medical School, International MD/PhD Program “Molecular Medicine” at Hannover Biomedical Research School (HBRS), Institute of Experimental Hematology ; Supervisor: Dr. med. Adrian Schwarzer, PhD, Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany, Prof. Dr. med. Axel Schambach, PhD, Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany, Co-supervisors: Prof. Dr. med. Michael Heuser, Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany, Prof. Dr. rer. nat. Dirk Heckl, Pediatric Hematology and Oncology, Martin-Luther-University Halle-Wittenberg, Halle, Germany